Tashkent Jean Monnet Centre of Excellence for European Studies



The main goal of the project is to support education and research in Uzbekistan in the areas of international politics, regional integration processes, EU studies, EU-Central Asia studies, and EU-Uzbekistan relations. The Tashkent Center for European Studies, which is being set up for this purpose, will coordinate political, economic and legal education and research across the country, and will serve as a scientific and methodological hub.

As its name suggests, the Project claims to be a focal point of competence and knowledge on European studies in Uzbekistan and centers around the answer to the question: why the EU studies is important for the most populated country of Central Asia which is located far away from Europe. Unsurprisingly, one could wonder whether it is useful to develop EU studies in Uzbekistan. In our vision, certainly, it is useful for two main reasons.

Latest News

On behalf of the EU Delegation to the Republic of Uzbekistan we would like to congratulate the University of World Economy and Diplomacy with the significant achievement of being selected as a European Union grantholder to establish the Tashkent Jean Monnet Centre of Excellence for European Studies.
It is worth to underline that it is a well-deserved recognition of the university team leaded by Professor Khaydarali Yunusov and its capacity which has been considerably increased within previous successfully implemented Jean Monnet projects!
Wishing the UWED and the Jean Monnet team a good start of this ambitious project and extended of Jean Monnet family by new universities of Uzbekistan!

The EU Delegationto the Republic of Uzbekistan

Teaching the EU Law in Uzbekistan…One could wonder whether it is useful to teach EU law in Uzbekistan. Certainly it is useful for two main reasons.
First of all, for those who will be involved in their professional career in exchanges with EU member States, it is necessary to know the rules of the European Single Market and the decision-making processes, and not only rules on relationships with third countries. Only if you understand the decision-making processes you can have an influence on the final decisions that are relevant for you.
Secondly, the EU is the most sophisticated regional integration system. The EU offers a rich experience from custom union to political integration. Studying this experience will be helpful to find out adequate forms of institutional cooperation in Central Asia.

Professor Gérard MarcouUniversity Paris 1 Panthéon-Sorbonne Sorbonne School of Law

The importance of EU-studies cannot be overestimated within as well as outside the European Union. The EU is not only one of the economically most advanced regions of the world and an extremely important trading partner. It is also a historically unique model for the integration of national economies into a single market based on the principles of democracy and the rule of law. The overall result has been peace and wellbeing of the people in the Union for many decades. EU law should therefore be studied everywhere. Teaching EU law, however, requires its own methodology and expertise. And it requires communication and cooperation among teachers from within and outside the EU. It is to be highly welcomed that this booklet provides an important contribution to the spreading of interest in teaching and studying EU law.

Professor Peter BehrensUniversity of Hamburg Director of the Institute for European Integration, Europa-Kolleg Hamburg

The efforts of Prof. Khaydarali Yunusov to advance teaching and research activities on European integration studies in Uzbekistan are well known in the European Union. I have highest respect for the progress made in this direction by his personal work and that of his university. The University of World Economy and Diplomacy has been a pioneer in Central Asia in this regard. I am convinced that my Uzbek colleagues will exert every effort to further studies on European integration and the meaning of these expertiences for the future of Central Asia. The high quality of the scholarly work of Prof. Yunusov deserved global recognition and every support in being rooted in the academic landscape of Central Asia, one of the emerging regions of our common globe.

Professor Ludger KühnhardtUniversity of Bonn Director of the Center for European Integration Studies (ZEI)
Vaccines and COVID-19: The latest hopeful research - knowledgeisle
Image default
Covid-19 Diseases Health

Vaccines and COVID-19: The latest hopeful research

What is the latest in COVID-19 vaccine advances? Can currently authorized vaccines protect against newly emerging SARS-CoV-2 variants? In this Hope Behind the Headlines feature, we examine these and other questions.

New, and possibly more contagious, variants of SARS-CoV-2 — which is the virus that causes COVID-19 — are emerging in countries around the world. Add to that the fact that the global number of COVID-19 cases is currently at over 95 million, and it can be difficult to remain optimistic that we will see the end of the pandemic anytime soon.

Yet scientists have not stopped working on vaccines, which are key to controlling the spread of the new coronavirus in the long run.

In this Hope Behind the Headlines feature, we look at what experts have to say about whether or not currently authorized vaccines are likely to protect us against new SARS-CoV-2 variants.

We also give an overview of a promising vaccine candidate currently under trial, which has recently made the headlines.

8 COVID-19 vaccines gained authorization

Experts have explained time and again that in order to contain SARS-CoV-2 and prevent more coronavirus outbreaks in the future, vaccines are of utmost importance.

At the moment, there are eight COVID-19 vaccines with authorization in countries around the world.

So far, the Pfizer-BioNTech vaccine, which is an mRNA vaccine, has gained authorization for use in 50 countries. These include the United States, the United Kingdom, and the 27 countries that make up the European Union.

The vaccine developed by Moderna and the National Institute of Allergy and Infectious Diseases (NIAID), which is also an mRNA vaccine, is currently authorized in 36 countries. These include the U.S., the U.K., and E.U. countries.

Sputnik V, which is a viral vector vaccine developed by the Russian research institute Gamaleya, is authorized in eight countries: Algeria, Argentina, Belarus, Bolivia, Guinea, Russia, Serbia, and West Bank.

Close on its heels is the Oxford-AstraZeneca viral vector vaccine, which has gained use authorization in seven countries. These are Argentina, the Dominican Republic, El Salvador, India, Mexico, Morocco, and the U.K.

Other vaccines that have gained authorization in certain countries are:

  • Covishield, a viral vector vaccine authorized in India
  • Covaxin, an inactivated vaccine authorized in India
  • the Sinopharm vaccine, also inactivated, which is authorized in six countries, including China, Egypt, and the United Arab Emirates
  • the Sinovac vaccine, also inactivated, which is authorized in China, Indonesia, and Turkey

At a global forum held on January 15, 2021, Dr. Tedros Adhanom Ghebreyesus — the World Health Organization’s (WHO) director-general — said: ….. Continue Reading…….

Related posts

Study shows that Health and well-being will improve if you spend time in the garden


What, Why and How: Proteins for thriving growth

Noah Liam

Coronavirus (COVID-19): Get answers of your questions…


Leave a Comment